Role of glutathione in reduction of arsenate and of γ-glutamyltranspeptidase in disposition of arsenite in rats
- 1 February 2005
- journal article
- Published by Elsevier in Toxicology
- Vol. 207 (1) , 91-104
- https://doi.org/10.1016/j.tox.2004.09.002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The potential of arsenic trioxide in the treatment of malignant disease: past, present, and futureLeukemia Research, 2004
- Dose-dependent biotransformation of arsenite in rats—not S-adenosylmethionine depletion impairs arsenic methylation at high doseToxicology, 2003
- Effect of selenite on the disposition of arsenate and arsenite in ratsToxicology, 2003
- Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolitesComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2002
- Role of MRP2 and GSH in intrahepatic cycling of toxinsToxicology, 2001
- Effect of Phosphate Transporter and Methylation Inhibitor Drugs on the Disposition of Arsenate and Arsenite in RatsToxicological Sciences, 2001
- Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox SystemBlood, 1999
- Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance studyChemico-Biological Interactions, 1994
- Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformationCarcinogenesis: Integrative Cancer Research, 1987
- The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformationBiochemical Pharmacology, 1984